Summary
We tested auditory spatial motion localisation in congenitally hearing impaired adult users of bilateral cochlear implants, and other hearing assistive devices. The group showed severely impaired capabilities despite extensive device use, emphasizing the role of nature in sensory development. We then investigate whether the deficit is maintained for other sensory modalities, by using an in-house sensory substitution device that provides weighted vibrotactile cues on fingertips to induce 3D spatial motion perception. The performance was significantly higher, both in the combined audio-tactile task and the tactile task itself, with accuracy comparable to typically hearing subjects. With touch, we also showed considerably fewer front-back and right-left confusions. The rapid audio-tactile binding and availability of 3D space representation through touch, point to the significant role of nurture in spatial perception development and its amodal nature. The findings show promise towards advancing multisensory solutions for spatial hearing rehabilitation.
Highlights
– Auditory motion localisation is severely impaired in aided congenitally hearing impaired, supporting the role of nature towards spatial development;
– Binding auditory and tactile information enhances auditory spatial performance, supporting the role of nurture;
– Hearing impaired individuals perform 360° motion localisation through touch with accuracy similar to typically hearing;
– Surrounding spatial representation never before experienced in congenitally hearing impaired is rapidly available through an alternate modality
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
an ERC Consolidator Grant (773121 NovelExperiSense), a Horizon GuestXR (101017884) grant, and a Joy Ventures grant (to AA)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Reichman University Review Board (approval no 2022123)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
